Biotechnology

Jyong Biotech

Jyong Biotech Stock Hits 52-Week Low

Jyong Biotech Completes Phase II Clinical Trial of MCS-8

Jyong Biotech Ltd. released FY2023 Annual Earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0614

Jyong Biotech Ltd. released FY2023 Q3 earnings on April 23 (EST), actual revenue USD 0, actual EPS USD -0.0185

Jyong Biotech Ltd. released FY2024 Q4 earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0118

Jyong Biotech Ltd. released FY2023 Q4 earnings on April 23, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.0185

Jyong Biotech Ltd. released FY2023 9 Months Earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0429

Jyong Biotech Ltd. released FY2024 Q3 earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0118

Jyong Biotech Ltd. released FY2024 9 Months earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0303

Jyong Biotech Ltd. released FY2024 Annual Earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0421

Jyong Biotech Ltd. released FY2023 Q1 earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0121

Jyong Biotech Ltd. released FY2023 Q2 earnings on October 4, 2024 (EST), with actual revenue of USD 0 and EPS of USD -0.0121

Jyong Biotech Ltd. released FY2023 Semi-Annual Earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0243

Jyong Biotech Ltd. released FY2024 Q2 earnings on October 4 (EST) with actual revenue of USD 0 and EPS of USD -0.0092

Jyong Biotech Ltd. released FY2024 Semi-Annual earnings on October 4, 2024 (EST) with actual revenue USD 0 and EPS USD -0.0185

Jyong Biotech Ltd. released FY2024 Q1 earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0092

Starfighters Space

Aimei Health Tech

T-Rex 2X Long DJT Daily Target ETF

Athira Pharma

Sable Offshore

Zeta Network

Vivakor

Safe and Green Development

Trump Media & Tech

VS MEDIA

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap